A review of the smallpox active surveillance system

被引:7
|
作者
Thomas, Tracy N. [1 ,2 ]
Reef, Susan [1 ]
Neff, Linda [1 ]
Sniadack, Mercedes M. [1 ,3 ]
Mootrey, Gina I. [1 ]
机构
[1] Ctr Dis Control & Prevent, Div Viral Dis, Natl Immunizat Program, Atlanta, GA 30333 USA
[2] Constella Grp, Durham, NC USA
[3] Logist Hlth, La Crosse, WI USA
关键词
D O I
10.1086/524742
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In response to concern about smallpox possibly being used as a biological weapon, the President of the United States launched the National Smallpox Pre-Event Vaccination Program on 13 December 2002. Given safety concerns, identifying potentially serious adverse events (SAEs) was an essential tool of the program. To monitor for SAEs, both enhanced passive surveillance and active surveillance systems were used. The enhanced passive system was built, in part, on the existing Vaccine Adverse Event Reporting System; the active system was implemented 24 January 2003. During January 2003-May 2005, the active system detected only 1 SAE in addition to those reported through the enhanced passive system. Furthermore, the active system was not universally used by states. With the enhancements to passive surveillance, the performance of enhanced passive surveillance was comparable to that of active surveillance. However, an active surveillance system may be important when there is no enhanced passive surveillance system available.
引用
收藏
页码:S212 / S220
页数:9
相关论文
共 50 条
  • [41] Active Surveillance in Small Renal Masses in the Elderly: A Literature Review
    Cheung, Douglas C.
    Finelli, Antonio
    EUROPEAN UROLOGY FOCUS, 2017, 3 (4-5): : 340 - 351
  • [42] Feasibility of active surveillance in small testicular mass: a mini review
    Niemczyk, Grzegorz
    Zapala, Lukasz
    Borkowski, Tomasz
    Szablonski, Waldemar
    Radziszewski, Piotr
    Cudnoch-Jedrzejewska, Agnieszka
    CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2021, 74 (01) : 10 - 13
  • [43] Active surveillance for prostate cancer: a narrative review of clinical guidelines
    Bruinsma, Sophie M.
    Bangma, Chris H.
    Carroll, Peter R.
    Leapman, Michael S.
    Rannikko, Antti
    Petrides, Neophytos
    Weerakoon, Mahesha
    Bokhorst, Leonard P.
    Roobol, Monique J.
    NATURE REVIEWS UROLOGY, 2016, 13 (03) : 151 - 167
  • [44] Active Surveillance in Men With Localized Prostate Cancer A Systematic Review
    Dahabreh, Issa J.
    Chung, Mei
    Balk, Ethan M.
    Yu, Winifred W.
    Mathew, Paul
    Lau, Joseph
    Ip, Stanley
    ANNALS OF INTERNAL MEDICINE, 2012, 156 (08) : 582 - U110
  • [45] Active surveillance: a review of risk-based, dynamic monitoring
    Nieboer, Daan
    Tomer, Anirudh
    Rizopoulos, Dimitris
    Roobol, Monique J.
    Steyerberg, Ewout W.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2018, 7 (01) : 106 - 115
  • [46] Active surveillance for prostate cancer: a narrative review of clinical guidelines
    Sophie M. Bruinsma
    Chris H. Bangma
    Peter R. Carroll
    Michael S. Leapman
    Antti Rannikko
    Neophytos Petrides
    Mahesha Weerakoon
    Leonard P. Bokhorst
    Monique J. Roobol
    Nature Reviews Urology, 2016, 13 : 151 - 167
  • [47] From smallpox to polio and beyond: disease surveillance in India
    Heymann, DL
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2004, 120 (02) : 70 - 72
  • [48] ACTIVE SURVEILLANCE
    Boorjian, Stephen A.
    Uzzo, Robert G.
    JOURNAL OF UROLOGY, 2010, 184 (02): : 420 - 422
  • [49] Is Active Surveillance Too Active?
    James T Kearns
    Brian T Helfand
    Current Urology Reports, 2023, 24 : 463 - 469
  • [50] Is Active Surveillance Too Active?
    Kearns, James T.
    Helfand, Brian T.
    CURRENT UROLOGY REPORTS, 2023, 24 (10) : 463 - 469